Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy

International Journal of Urology

Volumn 20, Issue 6, 2013, Pages 594-601

  Fujita, Kazutoshi ^a   Tanigawa, Go ^a   Imamura, Ryoichi ^a   Nakagawa, Masahiro ^a   Hayashi, Takuji ^a   Kishimoto, Nozomu ^a   Hosomi, Masahiro ^a   Yamaguchi, Seiji ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Nephroureterectomy; Preoperative prognostic marker; Sodium; Survival; Upper urinary tract urothelial carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; SODIUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; TRANSITIONAL CELL CARCINOMA; UPPER URINARY TRACT UROTHELIAL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SODIUM; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84878630129     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03228.x     Document Type: Article

References (24)

1. Colin P, Koenig P, Ouzzane A etal. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009; 104: 1436-1440.
2. Martinez-Salamanca JI, Shariat SF, Rodriguez JC etal. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2012; 109: 1155-1161.
3. Shariat SF, Godoy G, Lotan Y etal. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010; 105: 1672-1677.
4. Kikuchi E, Margulis V, Karakiewicz PI etal. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J. Clin. Oncol. 2009; 27: 612-618.
5. Ouzzane A, Colin P, Xylinas E etal. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur. Urol. 2011; 60: 1258-1265.
6. Margulis V, Shariat SF, Matin SF etal. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233.
7. Saito K, Kawakami S, Ohtsuka Y etal. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007; 100: 269-273.
8. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am. J. Kidney Dis. 2012; 59: 222-228.
9. Huo TI, Lin HC, Hsia CY etal. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig. Liver Dis. 2008; 40: 882-889.
10. Hansen O, Sorensen P, Hansen KH. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer 2010; 68: 111-114.
11. Kim HS, Yi SY, Jun HJ etal. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 2007; 73: 192-197.
12. Jeppesen AN, Jensen HK, Donskov F, Marcussen N, von der Maase H. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma. Br. J. Cancer 2010; 102: 867-872.
13. Vasudev NS, Brown JE, Brown SR etal. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin. Cancer Res. 2008; 14: 1775-1781.
14. Suyama T, Nakajima K, Kanbe S, Tanaka N, Hara H, Ishii N. Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma. Int. J. Urol. 2011; 18: 43-47.
15. Cha EK, Shariat SF, Kormaksson M etal. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur. Urol. 2012; [in print].
16. Jeldres C, Sun M, Lughezzani G etal. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 2010; 116: 3774-3784.
17. Elhassan EA, Schrier RW. Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists. Curr. Opin. Nephrol. Hypertens. 2011; 20: 161-168.
18. Sajadieh A, Binici Z, Mouridsen MR, Nielsen OW, Hansen JF, Haugaard SB. Mild hyponatremia carries a poor prognosis in community subjects. Am. J. Med. 2009; 122: 679-686.
19. Gheorghiade M, Abraham WT, Albert NM etal. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur. Heart J. 2007; 28: 980-988.
20. Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: pathophysiology, presentation, diagnosis, and treatment. CA Cancer J. Clin. [in print].
21. Bolignano D, Medici MA, Coppolino G etal. Aquaretic inhibits renal cancer proliferation: role of vasopressin receptor-2 (V2-R). Urol. Oncol. 2010; 28: 642-647.
22. Alonso DF, Skilton G, Farias EF, Bal de Kier Joffe E, Gomez DE. Antimetastatic effect of desmopressin in a mouse mammary tumor model. Breast Cancer Res. Treat. 1999; 57: 271-275.
23. Swart RM, Hoorn EJ, Betjes MG, Zietse R. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011; 118: 45-51.
24. Seguchi T, Yokokawa K, Sugao H, Nakano E, Sonoda T, Okuyama A. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J. Urol. 1992; 148: 791-794.